Clinical Trials Browser

Phase 2/3 × Breast Neoplasms × Albumin-Bound Paclitaxel × Clear all

NCT01881230 2019-02-21

tnAcity

Phase 2/3 Completed

191 enrolled 22 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01647672 2012-07-25

Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer

Phase 2/3 Unknown

Breast Neoplasms